Does RIPRETINIB Cause Disease progression? 290 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 290 reports of Disease progression have been filed in association with RIPRETINIB (QINLOCK). This represents 6.5% of all adverse event reports for RIPRETINIB.
290
Reports of Disease progression with RIPRETINIB
6.5%
of all RIPRETINIB reports
67
Deaths
48
Hospitalizations
How Dangerous Is Disease progression From RIPRETINIB?
Of the 290 reports, 67 (23.1%) resulted in death, 48 (16.6%) required hospitalization, and 2 (0.7%) were considered life-threatening.
Is Disease progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RIPRETINIB. However, 290 reports have been filed with the FAERS database.
What Other Side Effects Does RIPRETINIB Cause?
Fatigue (582)
Alopecia (517)
Extra dose administered (357)
Death (356)
Underdose (345)
Nausea (292)
Drug ineffective (291)
Hospitalisation (280)
Neoplasm progression (263)
Constipation (249)
What Other Drugs Cause Disease progression?
RITUXIMAB (7,282)
CYCLOPHOSPHAMIDE (7,100)
DOXORUBICIN (6,165)
VINCRISTINE (5,252)
PREDNISONE (5,096)
BEVACIZUMAB (4,653)
DEXAMETHASONE (4,545)
CARBOPLATIN (4,538)
CAPECITABINE (3,808)
ETOPOSIDE (3,776)
Which RIPRETINIB Alternatives Have Lower Disease progression Risk?
RIPRETINIB vs RISANKIZUMAB
RIPRETINIB vs RISANKIZUMAB-RZAA
RIPRETINIB vs RISDIPLAM
RIPRETINIB vs RISEDRONATE
RIPRETINIB vs RISEDRONIC ACID